Starbucks Corp
NASDAQ: SBUX
$96.08
-$1.01 (-1.0%)
Closing Price on November 6, 2024
SBUX Articles
Starbucks reported mixed fiscal first-quarter financial results after markets closed Tuesday, and shares retreated early Wednesday.
Published:
A busy week for quarterly earnings reports continues with one of the country's trillion-dollar firms and a chipmaker that doubled its share price last year.
Published:
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week.
Published:
Goldman Sachs has four out-of-favor stock picks have been reasonably strong but still have double-digit upside potential for 2021. Plus, they act somewhat defensively when the going gets tough.
Published:
Tuesday afternoon's analyst calls included McDonald's, Qualcomm, Roku, Starbucks, Tesla and more.
Published:
Thursday's top analyst upgrades and downgrades included Best Buy, Booking, ConocoPhillips, CRISPR Therapeutics, Fisker, Halliburton, Lordstown Motors, RH, Tesla, Walt Disney and Zscaler.
Published:
We could be in for some rocky trading days, especially if the final election results are delayed. These are good ideas for growth stock investors looking to stay in the market but dial down risk...
Published:
Friday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Callaway Golf, Facebook, Illumina, iRobot, Six Flags, Starbucks, Twitter and Yandex.
Published:
Starbucks had seen growth for years and years, taking over the coffee scene by force. The retailer has now released its earnings for its fiscal fourth quarter of 2020.
Published:
This week will be perhaps the biggest week of earnings season, with many major names reporting, including Amazon, Facebook, Ford and Starbucks.
Published:
Monday's top analyst upgrades and downgrades included Archer Daniels Midland, AMC, CarMax, Chevron, Exxon Mobil, GoodRx, Laird Superfood, Snap, Starbucks and Tesla.
Published:
Friday's top analyst upgrades and downgrades included AGCO, Caterpillar, Chewy, Clorox, Costco Wholesale, First Solar, Netflix, Snap, Starbucks and Wynn Resorts.
Published:
Last Updated:
Wednesday's top analyst upgrades and downgrades included Delta Air Lines, Hasbro, Illumina, Lululemon Athletica, Micron Technologies, Nike, Penn National, Shopify, Southwest Airlines, Starbucks and...
Published:
Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.
Published:
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
Published: